A syndicate of investors led by Flerie Invest AB acquired Cobra Biologics Matfors Ab from Charles River Laboratories International, Inc. (NYSE:CRL) for $77 million on October 12, 2021. The new entity will be called NorthX Biologics AB. A syndicate of investors led by Flerie Invest AB completed the acquisition of Cobra Biologics Matfors Ab from Charles River Laboratories International, Inc. (NYSE:CRL) on October 12, 2021.